Novavax Stock Plunges 25% As Vaccine Maker Has ‘Substantial Doubt’ About Staying In Business

  • 📰 Forbes
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 53%

Business News News

Business Business Latest News,Business Business Headlines

Shares of the pharmaceutical company have slipped below $7 after trading well above $300 at points in 2021.

Shares of Novavax fell more than 25% in after-hours trading Tuesday, following a dismal fourth quarter earnings report and a

Novavax reported fourth quarter losses of $182 million after only posting $357 million in sales—well below expectations of $383 million.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Monster Beverage stock dives 6% as earnings and sales miss, stock split and price increases plannedMonster Beverage Corp. shares dove 6% in after-hours trading Tuesday, after the energy-drink company reported holiday earnings and sales lower than Wall...
Source: MarketWatch - 🏆 3. / 97 Read more »